5 Investors to Follow Other Than Warren Buffett
There is no doubt that Warren Buffett is one of…
Sell
47
IBBQ Quote, Financials, Valuation and Earnings
Last price:
$19.87
Seasonality move
:
5.91%
Day range:
$19.79 - $20.02
52-week range:
$17.84 - $24.84
Dividend yield:
1.22%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
20.4K
Avg. volume:
11.6K
1-year change:
-1.21%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
IBBQ
Invesco Nasdaq Biotechnology ETF
|
-- | -- | -- | -- | -- |
|
BBP
Virtus LifeSci Biotech Products ETF
|
-- | -- | -- | -- | -- |
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
-- | -- | -- | -- | -- |
|
IBB
iShares Biotechnology ETF
|
-- | -- | -- | -- | -- |
|
SBIO
ALPS Medical Breakthroughs ETF
|
-- | -- | -- | -- | -- |
|
XHS
SPDR S&P Health Care Services ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
IBBQ
Invesco Nasdaq Biotechnology ETF
|
$19.90 | -- | -- | -- | $0.04 | 1.22% | -- |
|
BBP
Virtus LifeSci Biotech Products ETF
|
$55.04 | -- | -- | -- | $0.00 | 0% | -- |
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
$156.25 | -- | -- | -- | $1.17 | 0.75% | -- |
|
IBB
iShares Biotechnology ETF
|
$119.40 | -- | -- | -- | $0.12 | 0.32% | -- |
|
SBIO
ALPS Medical Breakthroughs ETF
|
$27.39 | -- | -- | -- | $1.17 | 4.28% | -- |
|
XHS
SPDR S&P Health Care Services ETF
|
$98.20 | -- | -- | -- | $0.04 | 0.33% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
IBBQ
Invesco Nasdaq Biotechnology ETF
|
-- | 1.176 | -- | -- |
|
BBP
Virtus LifeSci Biotech Products ETF
|
-- | 1.267 | -- | -- |
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
-- | 1.052 | -- | -- |
|
IBB
iShares Biotechnology ETF
|
-- | 1.260 | -- | -- |
|
SBIO
ALPS Medical Breakthroughs ETF
|
-- | 1.374 | -- | -- |
|
XHS
SPDR S&P Health Care Services ETF
|
-- | 1.308 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
IBBQ
Invesco Nasdaq Biotechnology ETF
|
-- | -- | -- | -- | -- | -- |
|
BBP
Virtus LifeSci Biotech Products ETF
|
-- | -- | -- | -- | -- | -- |
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
-- | -- | -- | -- | -- | -- |
|
IBB
iShares Biotechnology ETF
|
-- | -- | -- | -- | -- | -- |
|
SBIO
ALPS Medical Breakthroughs ETF
|
-- | -- | -- | -- | -- | -- |
|
XHS
SPDR S&P Health Care Services ETF
|
-- | -- | -- | -- | -- | -- |
Invesco Nasdaq Biotechnology ETF vs. Competitors
-
Which has Higher Returns IBBQ or BBP?
Virtus LifeSci Biotech Products ETF has a net margin of -- compared to Invesco Nasdaq Biotechnology ETF's net margin of --. Invesco Nasdaq Biotechnology ETF's return on equity of -- beat Virtus LifeSci Biotech Products ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IBBQInvesco Nasdaq Biotechnology ETF-- -- -- BBPVirtus LifeSci Biotech Products ETF-- -- -- -
What do Analysts Say About IBBQ or BBP?
Invesco Nasdaq Biotechnology ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Virtus LifeSci Biotech Products ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco Nasdaq Biotechnology ETF has higher upside potential than Virtus LifeSci Biotech Products ETF, analysts believe Invesco Nasdaq Biotechnology ETF is more attractive than Virtus LifeSci Biotech Products ETF.
Company Buy Ratings Hold Ratings Sell Ratings IBBQInvesco Nasdaq Biotechnology ETF0 0 0 BBPVirtus LifeSci Biotech Products ETF0 0 0 -
Is IBBQ or BBP More Risky?
Invesco Nasdaq Biotechnology ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Virtus LifeSci Biotech Products ETF has a beta of 0.610, suggesting its less volatile than the S&P 500 by 38.994%.
-
Which is a Better Dividend Stock IBBQ or BBP?
Invesco Nasdaq Biotechnology ETF has a quarterly dividend of $0.04 per share corresponding to a yield of 1.22%. Virtus LifeSci Biotech Products ETF offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Invesco Nasdaq Biotechnology ETF pays -- of its earnings as a dividend. Virtus LifeSci Biotech Products ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IBBQ or BBP?
Invesco Nasdaq Biotechnology ETF quarterly revenues are --, which are smaller than Virtus LifeSci Biotech Products ETF quarterly revenues of --. Invesco Nasdaq Biotechnology ETF's net income of -- is lower than Virtus LifeSci Biotech Products ETF's net income of --. Notably, Invesco Nasdaq Biotechnology ETF's price-to-earnings ratio is -- while Virtus LifeSci Biotech Products ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco Nasdaq Biotechnology ETF is -- versus -- for Virtus LifeSci Biotech Products ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IBBQInvesco Nasdaq Biotechnology ETF-- -- -- -- BBPVirtus LifeSci Biotech Products ETF-- -- -- --
-
Which has Higher Returns IBBQ or FBT?
First Trust NYSE Arca Biotechnology Index Fund has a net margin of -- compared to Invesco Nasdaq Biotechnology ETF's net margin of --. Invesco Nasdaq Biotechnology ETF's return on equity of -- beat First Trust NYSE Arca Biotechnology Index Fund's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IBBQInvesco Nasdaq Biotechnology ETF-- -- -- FBTFirst Trust NYSE Arca Biotechnology Index Fund-- -- -- -
What do Analysts Say About IBBQ or FBT?
Invesco Nasdaq Biotechnology ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand First Trust NYSE Arca Biotechnology Index Fund has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco Nasdaq Biotechnology ETF has higher upside potential than First Trust NYSE Arca Biotechnology Index Fund, analysts believe Invesco Nasdaq Biotechnology ETF is more attractive than First Trust NYSE Arca Biotechnology Index Fund.
Company Buy Ratings Hold Ratings Sell Ratings IBBQInvesco Nasdaq Biotechnology ETF0 0 0 FBTFirst Trust NYSE Arca Biotechnology Index Fund0 0 0 -
Is IBBQ or FBT More Risky?
Invesco Nasdaq Biotechnology ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison First Trust NYSE Arca Biotechnology Index Fund has a beta of 0.683, suggesting its less volatile than the S&P 500 by 31.689%.
-
Which is a Better Dividend Stock IBBQ or FBT?
Invesco Nasdaq Biotechnology ETF has a quarterly dividend of $0.04 per share corresponding to a yield of 1.22%. First Trust NYSE Arca Biotechnology Index Fund offers a yield of 0.75% to investors and pays a quarterly dividend of $1.17 per share. Invesco Nasdaq Biotechnology ETF pays -- of its earnings as a dividend. First Trust NYSE Arca Biotechnology Index Fund pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IBBQ or FBT?
Invesco Nasdaq Biotechnology ETF quarterly revenues are --, which are smaller than First Trust NYSE Arca Biotechnology Index Fund quarterly revenues of --. Invesco Nasdaq Biotechnology ETF's net income of -- is lower than First Trust NYSE Arca Biotechnology Index Fund's net income of --. Notably, Invesco Nasdaq Biotechnology ETF's price-to-earnings ratio is -- while First Trust NYSE Arca Biotechnology Index Fund's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco Nasdaq Biotechnology ETF is -- versus -- for First Trust NYSE Arca Biotechnology Index Fund. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IBBQInvesco Nasdaq Biotechnology ETF-- -- -- -- FBTFirst Trust NYSE Arca Biotechnology Index Fund-- -- -- --
-
Which has Higher Returns IBBQ or IBB?
iShares Biotechnology ETF has a net margin of -- compared to Invesco Nasdaq Biotechnology ETF's net margin of --. Invesco Nasdaq Biotechnology ETF's return on equity of -- beat iShares Biotechnology ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IBBQInvesco Nasdaq Biotechnology ETF-- -- -- IBBiShares Biotechnology ETF-- -- -- -
What do Analysts Say About IBBQ or IBB?
Invesco Nasdaq Biotechnology ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares Biotechnology ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco Nasdaq Biotechnology ETF has higher upside potential than iShares Biotechnology ETF, analysts believe Invesco Nasdaq Biotechnology ETF is more attractive than iShares Biotechnology ETF.
Company Buy Ratings Hold Ratings Sell Ratings IBBQInvesco Nasdaq Biotechnology ETF0 0 0 IBBiShares Biotechnology ETF0 0 0 -
Is IBBQ or IBB More Risky?
Invesco Nasdaq Biotechnology ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison iShares Biotechnology ETF has a beta of 0.818, suggesting its less volatile than the S&P 500 by 18.239%.
-
Which is a Better Dividend Stock IBBQ or IBB?
Invesco Nasdaq Biotechnology ETF has a quarterly dividend of $0.04 per share corresponding to a yield of 1.22%. iShares Biotechnology ETF offers a yield of 0.32% to investors and pays a quarterly dividend of $0.12 per share. Invesco Nasdaq Biotechnology ETF pays -- of its earnings as a dividend. iShares Biotechnology ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IBBQ or IBB?
Invesco Nasdaq Biotechnology ETF quarterly revenues are --, which are smaller than iShares Biotechnology ETF quarterly revenues of --. Invesco Nasdaq Biotechnology ETF's net income of -- is lower than iShares Biotechnology ETF's net income of --. Notably, Invesco Nasdaq Biotechnology ETF's price-to-earnings ratio is -- while iShares Biotechnology ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco Nasdaq Biotechnology ETF is -- versus -- for iShares Biotechnology ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IBBQInvesco Nasdaq Biotechnology ETF-- -- -- -- IBBiShares Biotechnology ETF-- -- -- --
-
Which has Higher Returns IBBQ or SBIO?
ALPS Medical Breakthroughs ETF has a net margin of -- compared to Invesco Nasdaq Biotechnology ETF's net margin of --. Invesco Nasdaq Biotechnology ETF's return on equity of -- beat ALPS Medical Breakthroughs ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IBBQInvesco Nasdaq Biotechnology ETF-- -- -- SBIOALPS Medical Breakthroughs ETF-- -- -- -
What do Analysts Say About IBBQ or SBIO?
Invesco Nasdaq Biotechnology ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand ALPS Medical Breakthroughs ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco Nasdaq Biotechnology ETF has higher upside potential than ALPS Medical Breakthroughs ETF, analysts believe Invesco Nasdaq Biotechnology ETF is more attractive than ALPS Medical Breakthroughs ETF.
Company Buy Ratings Hold Ratings Sell Ratings IBBQInvesco Nasdaq Biotechnology ETF0 0 0 SBIOALPS Medical Breakthroughs ETF0 0 0 -
Is IBBQ or SBIO More Risky?
Invesco Nasdaq Biotechnology ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison ALPS Medical Breakthroughs ETF has a beta of 0.811, suggesting its less volatile than the S&P 500 by 18.871%.
-
Which is a Better Dividend Stock IBBQ or SBIO?
Invesco Nasdaq Biotechnology ETF has a quarterly dividend of $0.04 per share corresponding to a yield of 1.22%. ALPS Medical Breakthroughs ETF offers a yield of 4.28% to investors and pays a quarterly dividend of $1.17 per share. Invesco Nasdaq Biotechnology ETF pays -- of its earnings as a dividend. ALPS Medical Breakthroughs ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IBBQ or SBIO?
Invesco Nasdaq Biotechnology ETF quarterly revenues are --, which are smaller than ALPS Medical Breakthroughs ETF quarterly revenues of --. Invesco Nasdaq Biotechnology ETF's net income of -- is lower than ALPS Medical Breakthroughs ETF's net income of --. Notably, Invesco Nasdaq Biotechnology ETF's price-to-earnings ratio is -- while ALPS Medical Breakthroughs ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco Nasdaq Biotechnology ETF is -- versus -- for ALPS Medical Breakthroughs ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IBBQInvesco Nasdaq Biotechnology ETF-- -- -- -- SBIOALPS Medical Breakthroughs ETF-- -- -- --
-
Which has Higher Returns IBBQ or XHS?
SPDR S&P Health Care Services ETF has a net margin of -- compared to Invesco Nasdaq Biotechnology ETF's net margin of --. Invesco Nasdaq Biotechnology ETF's return on equity of -- beat SPDR S&P Health Care Services ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IBBQInvesco Nasdaq Biotechnology ETF-- -- -- XHSSPDR S&P Health Care Services ETF-- -- -- -
What do Analysts Say About IBBQ or XHS?
Invesco Nasdaq Biotechnology ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand SPDR S&P Health Care Services ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco Nasdaq Biotechnology ETF has higher upside potential than SPDR S&P Health Care Services ETF, analysts believe Invesco Nasdaq Biotechnology ETF is more attractive than SPDR S&P Health Care Services ETF.
Company Buy Ratings Hold Ratings Sell Ratings IBBQInvesco Nasdaq Biotechnology ETF0 0 0 XHSSPDR S&P Health Care Services ETF0 0 0 -
Is IBBQ or XHS More Risky?
Invesco Nasdaq Biotechnology ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison SPDR S&P Health Care Services ETF has a beta of 1.046, suggesting its more volatile than the S&P 500 by 4.633%.
-
Which is a Better Dividend Stock IBBQ or XHS?
Invesco Nasdaq Biotechnology ETF has a quarterly dividend of $0.04 per share corresponding to a yield of 1.22%. SPDR S&P Health Care Services ETF offers a yield of 0.33% to investors and pays a quarterly dividend of $0.04 per share. Invesco Nasdaq Biotechnology ETF pays -- of its earnings as a dividend. SPDR S&P Health Care Services ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IBBQ or XHS?
Invesco Nasdaq Biotechnology ETF quarterly revenues are --, which are smaller than SPDR S&P Health Care Services ETF quarterly revenues of --. Invesco Nasdaq Biotechnology ETF's net income of -- is lower than SPDR S&P Health Care Services ETF's net income of --. Notably, Invesco Nasdaq Biotechnology ETF's price-to-earnings ratio is -- while SPDR S&P Health Care Services ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco Nasdaq Biotechnology ETF is -- versus -- for SPDR S&P Health Care Services ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IBBQInvesco Nasdaq Biotechnology ETF-- -- -- -- XHSSPDR S&P Health Care Services ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is BYD a Threat To Tesla Shareholders?
BYD (OTC:BYDDY) has rocketed to the top of China’s booming…
CVX Vs XOM Stock, Which Energy Play Is Best?
Chevron (NYSE:CVX) and Exxon Mobil (NYSE:XOM) are two of the…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 32x
Buy
61
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Buy
60
RGC alert for May 8
Regencell Bioscience Holdings [RGC] is up 10.54% over the past day.
Buy
92
TPB alert for May 8
Turning Point Brands [TPB] is down 6.67% over the past day.
Buy
74
LIVN alert for May 8
LivaNova PLC [LIVN] is up 1.33% over the past day.
